Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Timothy M. Nywening, Andrea Wang‐Gillam, Dominic E. Sanford, Brian A. Belt, Roheena Z. Panni, Brian Cusworth, Adetunji T. Toriola, Rebecca Nieman, Lori A. Worley, Motoyo Yano,

The Lancet Oncology · 2016 · 778 citations · 24 references

DOIFull text

Open access

Concepts

References

24